Meihua International Medical Technologies Co Ltd (MHUA) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Meihua International Medical Technologies Co Ltd stock (MHUA) is currently trading at $7.61. Meihua International Medical Technologies Co Ltd PE ratio is 0.25. Meihua International Medical Technologies Co Ltd PS ratio (Price-to-Sales) is 4.75. WallStSmart rates MHUA as Sell.
- MHUA PE ratio analysis and historical PE chart
- MHUA PS ratio (Price-to-Sales) history and trend
- MHUA intrinsic value — DCF, Graham Number, EPV models
- MHUA stock price prediction 2025 2026 2027 2028 2029 2030
- MHUA fair value vs current price
- MHUA insider transactions and insider buying
- Is MHUA undervalued or overvalued?
- Meihua International Medical Technologies Co Ltd financial analysis — revenue, earnings, cash flow
- MHUA Piotroski F-Score and Altman Z-Score
- MHUA analyst price target and Smart Rating
Meihua International Medical Technologies Co
📊 No data available
Try selecting a different time range
MHUA Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · Meihua International Medical Technologies Co Ltd (MHUA)
MHUA trades at a significant discount to its Graham intrinsic value of $210.80, offering a 96% margin of safety — a level value investors typically seek before buying.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
Meihua International Medical Technologies Co Ltd (MHUA) · 9 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book. Concerns around return on equity and operating margin. Significant fundamental concerns warrant caution or avoidance.
Meihua International Medical Technologies Co Ltd (MHUA) Key Strengths (1)
Trading below book value, meaning the market prices it less than net assets
Supporting Valuation Data
Meihua International Medical Technologies Co Ltd (MHUA) Areas to Watch (8)
Revenue declining -16.20%, a shrinking business
Earnings declining -42.00%, profits shrinking
Very thin margins with limited operational efficiency
Very low institutional interest at 0.23%
Low profitability relative to shareholder equity
Premium valuation at 4.8x annual revenue
Small-cap company with higher risk but more growth potential
Decent profitability, keeps $10 per $100 revenue
Meihua International Medical Technologies Co Ltd (MHUA) Detailed Analysis Report
Overall Assessment
This company scores 34/100 in our Smart Analysis, earning a F grade. Out of 9 metrics analyzed, 1 register as strengths (avg 10.0/10) while 8 fall into concern territory (avg 2.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book. Valuation metrics including Price/Book (0.05) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Revenue Growth, EPS Growth, Operating Margin. Some valuation metrics including Price/Sales (4.75) suggest expensive pricing. Growth concerns include Revenue Growth at -16.20%, EPS Growth at -42.00%, which may limit upside. Profitability pressure is visible in Return on Equity at 5.90%, Operating Margin at 8.53%, Profit Margin at 10.30%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Revenue Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 5.90% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -16.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Revenue Growth and EPS Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
MHUA Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
MHUA's Price-to-Sales ratio of 4.75x sits near its historical average of 4.75x (0th percentile), suggesting the market is pricing in steady-state growth. The current valuation is 0% below its historical high of 4.75x set in Mar 2026, and 0% above its historical low of 4.75x in Mar 2026.
Compare MHUA with Competitors
Top MEDICAL INSTRUMENTS & SUPPLIES stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for Meihua International Medical Technologies Co Ltd (MHUA) · HEALTHCARE › MEDICAL INSTRUMENTS & SUPPLIES
The Big Picture
Meihua International Medical Technologies Co Ltd faces headwinds with declining revenue, though profitability provides a cushion. Revenue reached 90M with 16% decline year-over-year. Profit margins of 10.3% are healthy, with room for further expansion as the business scales.
Key Findings
Debt-to-equity ratio of 0.07 indicates a conservative balance sheet with 16M in cash.
Revenue contracted 16% YoY. Worth determining whether this is cyclical or structural.
Free cash flow is -20M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Margin expansion: can Meihua International Medical Technologies Co Ltd push profit margins above 15% as the business scales?
Sector dynamics: monitor MEDICAL INSTRUMENTS & SUPPLIES industry trends, competitive moves, and regulatory changes that could impact Meihua International Medical Technologies Co Ltd.
Bottom Line
Meihua International Medical Technologies Co Ltd faces challenges with declining revenue. While profitability provides a buffer, the long-term trajectory needs to improve. Watch for management's strategic response and whether the company can stabilize or pivot to new growth drivers.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About Meihua International Medical Technologies Co Ltd(MHUA)
NASDAQ
HEALTHCARE
MEDICAL INSTRUMENTS & SUPPLIES
USA
Meihua International Medical Technologies Co., Ltd. is engaged in the manufacturing and marketing of medical consumables in the People's Republic of China.